The vaccine that’s helped protect millions of people worldwide from the COVID-19 virus and its variants would not have been ...

London-based GSK is crossing the pond to form a new lung disease research collaboration with Boston scientists. | ...

With the appointment of Christian Tucat as CEO, Sciensus aims to leverage insights and expand its global reach in delivering lifesaving drugs and therapies.

The global malaria treatment market is projected to be valued at approximately USD 1.8 billion in the fiscal year 2023, an ...

The job sector in the United Kingdom provides numerous chances for international workers, particularly via the UK Work Visa. According to Last Stop Booking, the average monthly income for positions in ...

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

The abbreviated new drug application (ANDA) for the product was filed with the USFDA by Granules Pharmaceuticals, Inc. (GPI), ...

Northwestern University sued vaccine maker Moderna, Inc. on Wednesday, October 16, in the U.S. District Court for the ...

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...

The Boston Globe reports on findings from researchers at Mass General Brigham who examined "reservoirs" of the covid virus that hide inside people after their acute infections have ended. Also in the ...